Delivery Order SPE2DR25D3101-SPE2DR26F5S31
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Metoprolol Succinate Extended-Release 25 mg tablets (1,000 count) on October 17, 2025, with a ceiling value of $2,676.16 and an ultimate completion date of October 20, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded to the pharmaceutical distributor. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of 1,000 tablets of Metoprolol Succinate Extended Release 50 mg, valued at $1,312.12. This competitively awarded, firm fixed-price delivery order was issued on August 4, 2025, with an ultimate completion date of August 5, 2025. The products will be delivered to Conshohocken, Pennsylvania, the company's headquarters location. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Metoprolol Succinate Extended Release 50 mg tablets (1,000 count) with a ceiling value of $1,698.57. This firm fixed price delivery order, awarded on August 12, 2025, represents a non-competitive set-aside procurement and is set to be completed by August 13, 2025. The pharmaceutical product will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen Drug...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of 1,000 tablets of Metoprolol Succinate Extended Release 50 mg, with a contract ceiling value of $4,081.00 and completion deadline of September 11, 2025. This is a firm fixed-price delivery order issued without set-aside restrictions, meaning it was competitively awarded. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains...
- The Defense Logistics Agency awarded a delivery order valued at $10,561.75 to AmerisourceBergen Drug Corp for the supply of Metoprolol Succinate Extended Release 50 mg tablets (1,000 count) on December 1, 2025, with a completion date of December 2, 2025. This competitively awarded, firm fixed-price delivery order was placed with no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Metoprolol Succinate Extended Release 50 mg tablets (100-count bottles) with a ceiling value of $1,239.66. This firm fixed-price delivery order is scheduled for ultimate completion by September 29, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Metoprolol Succinate Extended Release 25 mg tablets in a quantity of 1,000 units, with a ceiling value of $4,275.31. This is a firm fixed price delivery order with no set-aside designation, utilizing open competition. The order is scheduled for ultimate completion by November 7, 2025, with performance to be executed from the contractor's Conshohocken, Pennsylvania location....
- The Defense Logistics Agency awarded a delivery order valued at $1,028.79 to AmerisourceBergen Drug Corp for 1,000 tablets of Metoprolol Succinate Extended-Release 25 mg on October 17, 2025, with completion scheduled for October 20, 2025. This firm fixed price, non-set-aside contract is being performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, is fulfilling...
- The Defense Logistics Agency awarded a $1,028.07 firm fixed-price delivery order to AmerisourceBergen Drug Corp for 1,000 tablets of Metoprolol Succinate Extended Release 100 mg, with an ultimate completion date of November 4, 2025. This non-set-aside contract was competitively awarded and will be performed at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor for federal medical procurement, is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Metoprolol Succinate Extended Release 25 mg tablets in quantities of 1,000 units. This firm fixed-price delivery order, valued at $1,542.30, represents a non-competitive set-aside contract and is scheduled for completion by August 28, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at...
- SPE2DR25D3101Indefinite Delivery Contract
- SPE2DR25D3101-SPE2DR26F5S31Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Metoprolol Succinate Extended Release 100 mg tablets (1,000 count) with a ceiling value of $2,111.66. This competitively awarded, non-set-aside delivery order was finalized on December 9, 2025, with an ultimate completion date of December 10, 2025. The pharmaceutical product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism, enabling the contractor to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, holds significant standing as a critical federal medical procurement vendor, delivering pharmaceuticals across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.1k | 12/8/25 |